AAV-U6/TO-shEsr1-CMV-TetR-eGFP
(Plasmid
#233298)
-
PurposeDOX-inducible U6 driven shRNA against mouse Esr1
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 233298 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepJEP10-AAV-U6/TO-gRNA(Empty)-CMV-TetR-P2A-eGFP-KASH-pA
-
Backbone manufacturerJonathan Ploski (Addgene #82706)
- Backbone size w/o insert (bp) 6298
- Total vector size (bp) 6240
-
Modifications to backboneRemove the sequence of gRNA scaffold
-
Vector typeMammalian Expression, AAV
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameEsr1 shRNA
-
Alt nameERα
-
gRNA/shRNA sequenceGGC ATG GAG CAT CTC TAC A
-
SpeciesM. musculus (mouse)
-
Entrez GeneEsr1 (a.k.a. ER, ER-alpha, ERa, ERalpha, ESR, Estr, Estra, Nr3a1)
- Promoter U6
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site SapI (not destroyed)
- 3′ cloning site XbaI (not destroyed)
- 5′ sequencing primer hU6-F (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
There is a D insertion after T52 upstream of TetR and does not affect function. The expression of TetR was confirmed using Western Blotting in in vitro cell culture experiment.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
AAV-U6/TO-shEsr1-CMV-TetR-eGFP was a gift from Dayu Lin (Addgene plasmid # 233298 ; http://n2t.net/addgene:233298 ; RRID:Addgene_233298) -
For your References section:
Estrogenic control of reward prediction errors and reinforcement learning. Golden CEM, Martin AC, Kaur D, Mah A, Levy DH, Yamaguchi T, Lasek AW, Lin D, Aoki C, Constantinople CM. bioRxiv [Preprint]. 2024 Sep 25:2023.12.09.570945. doi: 10.1101/2023.12.09.570945. 10.1101/2023.12.09.570945 PubMed 38105956